Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Auditor change
BIOENVISION INC (BIVN) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/11/2017 GN MonoSol Rx Appoints James S. Scibetta to Board of Directors
05/12/2008 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2008 SC 13G/A FEDERATED INVESTORS INC reports a 5.2% stake in BIOENVISION, INC.
10/26/2007 SC 13D/A LEHMAN BROTHERS HOLDINGS INC reports a 0% stake in BIOENVISION, INC.
10/25/2007 SC 13D/A LEHMAN BROTHERS HOLDINGS INC reports a 0% stake in BIOENVISION, INC.
10/24/2007 SC 13D/A GENZYME CORP reports a 100% stake in BIOENVISION, INC.
10/11/2007 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
10/11/2007 8-K Quarterly results
10/10/2007 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
10/10/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "Bioenvision and Genzyme File Petition in Delaware Court Petition Seeks Special Meeting to be Reconvened in late October to Reopen Polls"
10/05/2007 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
10/05/2007 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
10/04/2007 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
10/01/2007 SC 13D/A SCO CAPITAL PARTNERS LLC reports a 13.1% stake in BIOENVISION, INC.
09/27/2007 SC 13D/A GENZYME CORP reports a 27.9% stake in BIOENVISION, INC.
09/20/2007 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
09/19/2007 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
09/12/2007 10-K Annual Report for the period ended June 30, 2007
09/12/2007 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
09/12/2007 SC 13D/A SCO CAPITAL PARTNERS LLC reports a 13.1% stake in BIOENVISION, INC.
09/12/2007 8-K Quarterly results
Docs: "Bioenvision Reports Financial Results for Fourth Quarter and Year End 2007 - Conference Call to be Held Today at 10:00 a.m. -"
09/07/2007 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition
09/06/2007 SC 13D/A ELLIOTT ASSOCIATES, L.P. reports a 4% stake in Bioenvision, Inc.
08/31/2007 8-K Other Events
08/22/2007 SC 13G EDELMAN JOSEPH reports a 12.1% stake in Bioenvision, Inc.
08/16/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "BIOENVISION PROVIDES EVOLTRA® REGULATORY UPDATE"
08/06/2007 SC 13D ELLIOTT ASSOCIATES, L.P. reports a 3.5% stake in Bioenvision, Inc.
08/02/2007 SC 13D/A GENZYME CORP reports a 27.9% stake in BIOENVISION, INC.
07/30/2007 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
07/27/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "CLASS ACTION COMPLAINT",
"Bioenvision, Inc. Says Securities Class Action Litigation Without Merit"
07/17/2007 SC 13D/A GENZYME CORP reports a 28.2% stake in BIOENVISION, INC.
07/16/2007 SC 13D/A GENZYME CORP reports a 28.2% stake in BIOENVISION, INC.
07/16/2007 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Press release"
07/12/2007 SC 13D/A PERSEUS SOROS BIOPHARMACEUTICAL FUND LP reports a 0% stake in BIOENVISION, INC.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy